Evaluation of antitumor activities of hyaluronate binding antitumor drugs: Synthesis, characterization and antitumor activity

Journal of Drug Targeting

Volumn 4, Issue 1, 1996, Pages 1-8

  Akima, Kazuo ^a   Ito, Hisashi ^b   Iwata, Yuhei ^a   Matsuo, Kayoko ^a   Watari, Nobutoshi ^a   Yanagi, Mitsuo ^a   Hagi, Hiroo ^b   Oshima, Kazumi ^b   Yagita, Akikuni ^b   Atomi, Yutaka ^b   Tatekawa, Isao ^b  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Drug targeting; HA receptor (CD44); HA mitomycin C complex; Lymph nodes; Metabolic study; Metastasis

Indexed keywords

EPIRUBICIN; FLUORESCENT DYE; HERMES ANTIGEN; HYALURONIC ACID DERIVATIVE; MITOMYCIN C DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DISTRIBUTION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG UPTAKE; ISOTOPE LABELING; LEWIS CARCINOMA; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9344229753     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869609046255     Document Type: Article

References (21)

1. Akasaka, H., Seto, S., Yanagi, M., and Mitsui, T. (1988) Industrial production of hyaluronic acid by Streptococcus zooepidemicus. J. Soc. Cosmet. Chem. Japan. 22, 35-42.
2. Akima, K., Sato, I., Hasegawa, M., Matsuo, K., Iwata, Y., and Watari, N. (1993) Studies on the metabolic fate of sodium hyaluronate(SL-1010) after intra-articular administration I - Distribution, metabolism and excretion after intra-articular injection into rabbit knee-. Xenobio. Metabol. and Dispos., 8, 333-347.
3. Akima, K., Matsuo, K., Watari, N., Moriya, Y., and Iwata, Y. (1993) Studies on the metabolic fate of sodium hyaluronate (SL-1010) after intra-articular administration III - Distribution of fluorescent SL-1010 after intra-articular injection into rabbit shoulder-. Jpn. Pharmacol. Ther., 21(Suppl.), s451-461.
4. Akima, K., Sato, I., Hasegawa, M., Matsuo, K., Iwata, Y., and Watari N. (1994) Studies on the metabolic fate of sodium hyaluronate(SL-1010) after intra-articular administration I - Distribution, metabolism and excretion after intra-articular injection into rabbit shoulder-. Xenobio. Metabol. and Dispos., 8, received.
5. Akima, K., Watari, N., Matsuo, K., Iwata, Y., Ito, H., Yagita, A., and Tatekawa, I. (1993) Evaluation of antirumor activities of hyaluronate binding antitumor drugs. International symposium: delivery of protein drugs-the next 10 years-, Kyoto, pp188-190.
6. Bitter, T., and Muir, H. M. (1962) A modified uronic acid carbazole reaction. Anal. Biochem., 4, 330-334.
7. Cera, C., Terbojevich, M., Cosani, A., and Palumbo, M. (1988) Anthracycline antibiotics supported on water-soluble polysaccharides: synthesis and physicochemical characterization. Int. J. Biol. Macromol., 10, 66-74.
8. Culty, M., Nguyen, H. A., and Underhill, C. B. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol., 116, 1055-1062.
9. Fraser, J. R. E., Kimpton, W. G., Laurent, T. C., Cahill, R. P., and Vakakis, N. (1988) Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J., 256, 153-158.
10. Gunthert, U., Hofman, M., Rudy, S., Reber, M., Zoller, L, Hausman, S., Matzku, A., Wenzel, A., Ponta, H., and Pals, S. T. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24.
11. Heider, K-H., Hofman, M., Hors, E., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. (1993) A human homologue of the rat metastasis associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120, 227-233.
12. Hofman, U., Rudy, W., Zooler, M., Tolg, C., Ponta, H., Herrlich, P., and Gunthert, U. (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human cell lines. Cancer Res., 51, 5292-5297.
13. Iwata, Y., Akima, K., and Sato, I. (1991) Studies of the metabolic fate of sodium hyaluronate(SL-1010) I - Distribution, metabolism and excretion after administration of SL-1010 into anterior chamber of rabbits-. Jpn. Pharmacol. Ther., 19(Suppl.), s309-326.
14. Iwata, Y., Akima, K., Sato, I., and Hasegawa, M. (1991) Studies of the metabolic fate of sodium hyaluronate(SL-1010) II - Distribution, metabolism and excretion after intravenous administration of SL-1010 in rabbits-. Jpn. Pharmacol. Ther., 19 (Suppl.), s335-356.
15. Iwata, Y., Akima, K., Sato, I., and Hasegawa, M. (1991) Studies of the metabolic fate of sodium hyaluronate(SL-1010) III - Distribution, metabolism and excretion after intravenous administration of SL-1010 in rats-. Jpn. Pharmacol. Ther., 19(Suppl.), s357-377.
16. Laurent, T. C., Ryan, M., Pietruszkiewicz, A. (1960) Fractionation of hyaluronic acid; The polydispersity of hyaluronic acid from the bovine vitreous body. Biochem. Biophys. Acta., 42, 476-485.
17. Matsumura, Y., and Tarin, D. (1993) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058.
18. Nemec, R. E., Toole, B. P., and Knudson, W. (1987) The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Biochem. Biophys. Res. Commun., 149, 249-257.
19. Ouchi, T., Fujino, A., Tanaka, K., and Banba, T. (1990) Synthesis and antitumor activity of conjugates of poly (α-malic acid) and 5-fluorouracils bound via ester, amide or carbamoyl bonds. J. Controlled Release. 12, 143-153.
20. Sy, M. S., Guo, Y-J., and Stamenkovic, I. (1992) Inhibition of tumor growth in vivo with a chimeric CD44-immunoglobulin molecule. J. Exp. Med., 176, 623-627.
21. Tanabe, K. K., Ellis, L. M., and Saya, H. (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341, 725-726.